Nexalis Therapeutics LimitedASX: NX1

First Patient Dosed for Phase 1, Pain Indication IRX211

Jun 7, 2023 at 4:15 AM UTC · Issued by Nexalis Therapeutics Limited

Nexalis Therapeutics Limited has released a press release.

View Attachment